Healthcare -
Biotechnology - NASDAQ - US
$ 14.7
4.33 %
$ 1.67 B
Market Cap
-3.88
P/E
DYN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DYN - Dyne Therapeutics, Inc.
-204 M
LAST VALUE
-82.76%
2 YEAR CAGR
-162.19%
5 YEAR CAGR
27.59%
10 YEAR CAGR